Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Fund Category
Scheme
Your result on : Select A Fund Family   |   Select a Category   |   Select a Scheme
Your are on :  Markets    |  Mutual Fund   |  Scheme Profile
Nippon India Nifty Pharma ETF
Summary Info
Fund Name : Nippon India Mutual Fund
Scheme Name : Nippon India Nifty Pharma ETF
AMC : Nippon India Mutual Fund
Type : Open
Category : Exchange Traded Funds (ETFs)
Launch Date : 21-Jun-21
Fund Manager : Himanshu Mange
Net Assets:(Rs. cr) 643.07
NAV Graph
NAV Details
NAV Date : 18-Apr-24
NAV [Rs] : 18.84
Buy/Resale Price [Rs] : 0.00
Sell/Repurchase Price [Rs] : 0.00
Entry Load % : Nil
Exit Load % : Nil
Latest Payouts
  Dividends Bonus
Ratio NA NA
Date NA NA
Investment Details
Tax Benefits : NA
Min. Investment(Rs.) : 1000
Increm.Investment(Rs.) : 0
Performance(%) Date :16-Apr-24
  1 Week 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year Since INC
Scheme Return -2.54 -0.17 8.09 23.41 50.57 NA NA 10.47
Category Avg -1.70 2.35 4.53 17.72 36.82 18.32 15.41 17.28
Category Best 3.28 12.45 21.57 56.60 106.37 55.37 25.15 81.97
Category Worst -4.29 -10.60 -8.48 -12.08 -17.71 -12.33 -6.07 -33.33
Statistical Ratios
What is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In simple words it shows the movement of the portfolio in comparison. The Higher the Beta, higher the volatility of the scheme to the index. If its greater than1 , then the portfolio is highly volatile to the movemnts in the index. If the beta is lesser than 1 , then scheme is less volatile to the index and beta which is close to 1 implies that the scheme is closely following the index.
Beta [%] SD [%] Sharpe Ratio [%] Jensons Alpha [%] ER [%]
0.9984 4.6195 0.3589 -0.2133 0.4520
Asset Allocation
Holdings 31-Mar-24
Company Name % Hold
Sun Pharma.Inds. 26.80
Cipla 12.03
Dr Reddy's Labs 11.48
Divi's Lab. 6.72
Lupin 5.98
Aurobindo Pharma 4.69
Zydus Lifesci. 3.90
Alkem Lab 3.80
Torrent Pharma. 3.64
Ipca Labs. 2.55
Mankind Pharma 2.54
Laurus Labs 2.36
Abbott India 2.21
Glenmark Pharma. 2.20
Gland Pharma 1.95
Biocon 1.80
J B Chem & Pharm 1.80
Natco Pharma 1.32
Sanofi India 1.12
Granules India 0.89
TREPS 0.23
Net CA & Others -0.01
C C I 0.00
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores
Investor Charter
STOCK BROKER DEPOSITORY PARTICIPANTS INVESTOR GRIEVANCES ESCALATION MATRIX
Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)